NNOX – Financial Treason & Crime

GLOBE NEWSWIRE, 06 April 2021

NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (“Nanox” or the “Company”), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2021. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov and on the Company’s website at www.nanox.vision under “Financials” in the Investors section. Continue reading “Article: NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F”

04/05/202104/13/2021

Article: Stock Alert: Nano-X Imaging Shares Gains 36% On 510 (K) Clearance For Nanox.ARC

Article - Media, Publications

Stock Alert: Nano-X Imaging Shares Gains 36% On 510 (K) Clearance For Nanox.ARC

RTTNews.com, 05 April 2021

(RTTNews) – Nano-X Imaging Ltd. (NNOX) shares are spiking on Monday morning trade as the medical imaging technology company’s single source Nanox.ARC digital x-ray technology received 510 (K) clearance from the FDA.

The Company expects to start system shipment in the fourth quarter of 2021 and the first quarter of 2022. Continue reading “Article: Stock Alert: Nano-X Imaging Shares Gains 36% On 510 (K) Clearance For Nanox.ARC”

12/02/202004/13/2021

Article: Why Nano-X Imaging Stock Continues to Surge

Article - Media, Publications

Why Nano-X Imaging Stock Continues to Surge

Rich Smith, 02 December 2020

Shares of Nano-X Imaging (NASDAQ: NNOX), the Israeli X-ray machine maker with the novel business idea of giving its products away for free (and then taking a cut of the revenue when doctors use the machines to take X-rays), is back in investors’ favor again. Over the past 10 days, shares of Nano-X have surged 79% — including a big 7% jump today as of 2:20 p.m. EST.

Why is Nano-X doing so well today? To learn the answer, you first have to go back in time a couple of months to mid-September, when Citron Research published a report branding Nano-X as “Theranos 2.0” and a company that not only “has never published any data showing their machine’s images compared to images from a standard CT scanner,” but has actually never even showed investors that it has a machine at all.

These and similar accusations from the short-seller devastated Nano-X’s stock over the summer, but on Thursday starting at 11:30 a.m. EST, Nano-X will attempt to refute all of the above by hosting “a live demonstration that will showcase the Nanox digital x-ray source tube and a range of 2D and 3D imaging applications performed by the Nanox.ARC at the 2020 Radiology Society of North America Virtual Annual Meeting.”

Read Full Article

09/23/202004/13/2021

Article: NNOX FRAUD ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nano-X Imaging (NNOX) Investors to Contact Its Attorneys: Securities Fraud Case Filed, Hedge Funds Call NNOX “Theranos 2.0” and “Garbage”

Article - Media, Publications

NNOX FRAUD ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nano-X Imaging (NNOX) Investors to Contact Its Attorneys: Securities Fraud Case Filed, Hedge Funds Call NNOX “Theranos 2.0” and “Garbage”

GLOBE NEWSWIRE, 23 September 2020/em>

The complaint alleges that throughout the Class Period, Defendants concealed that Nano-X’s: (1) commercial agreements and customers were fabricated; (2) statements regarding its novel Nanox System were misleading; and (3) Nano-X’s submission to the FDA admitted the Nanox System was not original.

Investors allegedly began to learn the truth on Sept. 15, 2020, when Citron Research published a report accusing Nano-X of conducting “the most blatant stock promotion we have seen in years.” Citron challenged Nano-X’s claimed new innovative technology, stating “we have not even seen proof of the product and have only seen a mockup drawing of what this machine is supposed to look like.” Citron also alleged that Nano-X’s commercial agreements “appear to be no more than fake customers.” Continue reading “Article: NNOX FRAUD ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nano-X Imaging (NNOX) Investors to Contact Its Attorneys: Securities Fraud Case Filed, Hedge Funds Call NNOX “Theranos 2.0” and “Garbage””

09/22/202004/13/2021

Article: Short-seller Muddy Waters takes aim at Nano-X Imaging after Citron

Article - Media, Publications

Short-seller Muddy Waters takes aim at Nano-X Imaging after Citron

Manas Mishra, 22 September 2021

(Reuters) – U.S.-listed shares of Israel’s Nano-X Imaging Ltd NNOX.O fell nearly 20% on Tuesday after short-seller Muddy Waters joined Citron Research in raising doubts over the company’s diagnostic product.

Muddy Waters likened the company to Nikola Corp NKLA.O, whose founder Trevor Milton stepped down on Monday amid scathing reports from short-sellers.

“We conclude that NNOX (Nano-X) has no real product to sell other than its stock,” Muddy Waters said in a report on Tuesday.

Read Full Article

09/18/202004/13/2021

Article: Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

Article - Media, Publications

Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

PRNewswire, 18 September 2020

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX). A complaint has been filed on behalf of investors who purchased the publicly traded securities of Nano-X between August 21, 2020 and September 15, 2020, inclusive (the “Class Period”).

According to the complaint, Nano-X’s securities began trading on the NASDAQ on August 21, 2020. Continue reading “Article: Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud”